University of Southern California

Research

COVID-19 Funding Opportunities

Jump to:

USC Funding
Keck School of Medicine

COVID-19 Federal Funding
Department of Commerce (DOC)
Department of Energy (DOE)
Department of State (DOS)
Department of State (DOS)
Food and Drug Administration (FDA)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Office of Science and Technology Policy (OSTP)
White House

COVID-19 Non-Federal Funding
American Lung Association
Andrew W. Mellon Foundation
Boehringer Ingelheim
California Breast Cancer Research Program (CBCRP)
Coalition for Epidemic Preparedness Innovations (CEPI)
COVID-19 Early Treatment Fund
DRIVe
Google
Patient-Centered Outcomes Research Institute
Paul Scherrer Institut
Stop the Spread
The Trinity Challenge
W.K. Kellogg Foundation

 

USC Funding

Keck School of Medicine

2/26 – The Keck School of Medicine COVID-19 research fund announces the second round of funding focused on research to mitigate the COVID-19 pandemic. In this round, the program will consider projects on any aspect of COVID-19 research but will place particular emphasis on the following, especially in combination: projects that leverage unique strengths of KSOM and USC, including our local communities, our health systems, our unique technical capabilities and our unique scientific expertise; projects that are relevant to vaccinations for COVID-19; projects related to novel diagnostic or therapeutic approaches, including consideration of viral mutability; projects focused on chronic COVID-19 complications; and/or projects that use the KSOM COVID 19 biorepository; projects that have the potential for rapid impact on the pandemic. Learn more at Keck COVID-19 Research Fund. Deadline: March 19, 2021.

 

COVID-19 Federal Funding

GrantForward has provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Grant COVID.

Department of Commerce (DOC)

3/30 – National Institute of Standards and Technology (NIST) invites Manufacturing USA institutes to propose high-impact projects designed to respond to the COVID-19 pandemic. Learn more at NIST Manufacturing USA National emergency Assistance Program. Deadline: Rolling.

 Back to Top

Department of Energy (DOE)

3/17 – The U.S. Department of Energy (DOE) encourages you to consider scientific questions that underpin COVID-19 response and that the research community may answer using DOE user facilities, computational resources, and enabling infrastructure. Learn more at DOE Seeking Input and Collaboration on Science and Technology Response to COVID-19. Deadline: Rolling.

 Back to Top

Department of State

8/05 – The U.S. Department of State, Office of Global Partnerships (E/GP) is pleased to announce the COVID-19 Private Sector Engagement & Partnership Fund (Fund) Annual Program Statement (APS) that will be used make assistance awards. Learn more at COVID-19 Private Sector Engagement & Partnership Fund. Deadline: May 28, 2021.

 Back to Top

National Aeronautics and Space Administration (NASA)

7/09 – Making Innovative Use of NASA Satellite Data to Address Environmental, Economic, and/or Societal Impacts of the COVID-19 pandemic. Learn more at Rapid Response and Novel Research in Earth Science. Deadline: Mar 29, 2021.

 Back to Top

National Institutes of Health (NIH)

4/9 – This Notice of Special Interest (NOSI) is being issued by the NIH Adherence Network through the Office of Behavioral and Social Sciences Research (OBSSR) with participation from multiple NIH Institutes, Centers, and Offices. This NOSI calls for research grant applications that address patient adherence to treatment and prevention regimens to promote health outcomes, including COVID-related issues. Learn more at: NOT-OD-21-100. Deadline: June 8, 2024.

4/9 – The purpose of this FOA is to support interdisciplinary community-engaged research designed to reduce or eliminate infections and sepsis as causes of pregnancy- related or associated morbidity and mortality (PRAMM) in regions of the United States with high rates of maternal mortality. This includes the obstetric-related causes of sepsis include endometritis, wound infection after cesarean section or episiotomy, and abdominopelvic abscess. However, pregnant women are also at risk for worse outcomes from pregnancy associated bacterial and viral infections such as influenza, urinary tract infections, and now COVID-19. Learn more at: RFA-HD-21-033. Deadline: May 20, 2021.

4/9 – The purpose of this Funding Opportunity Announcement (FOA) is to fund P50 Centers dedicated to advancing a national telehealth research agenda focused on improving cancer-related care and outcomes across the cancer control continuum in a rapidly changing healthcare, policy, technology, and communication environment, including examining the rapid adoption of telehealth due to COVID-19. Learn more at: RFA-CA-21-029. Deadline: July 20, 2021.

4/9 – The purpose of this Cooperative Resource-Related Research Project FOA is to establish a coordinating center to support and develop research, dissemination, and various data sharing activities for social, behavioral, and economic research on COVID-19. Learn more at: RFA-AG-21-035. Deadline: June 9, 2021.

4/9 – The purpose of this FOA is to advance research on the impact of SARS-CoV-2 and associated mitigation efforts on individual, family, and community behavior and on how subsequent economic disruption affects health-related outcomes, with close attention to underserved and vulnerable populations. Learn more at: PAR-21-213. Deadline: June 9, 2021 and November 8, 2021.

4/2 – The purpose of this Funding Opportunity Announcement (FOA) is to support applications that address the RESPOND pillar of the Ending the HIV Epidemic: A Plan for America (EHE) initiative. Health systems need to adapt to more rapidly detect transmissions, identify outbreaks, and guide tailored decision-making, particularly as the epidemiology of HIV changes due to successful public health interventions or unanticipated care disruptions such as the COVID-19 pandemic. Learn more at: RFA-AI-21-023. Deadline: July 31, 2021.

4/2 – The purpose of this Notice is to alert the community that NIH plans to publish a Research Opportunity (RO) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADxSM-UP) initiative to solicit research on COVID-19 diagnostic testing approaches to safely return children and staff to the in-person school setting in underserved and vulnerable communities (NOT-OD-21-065). Learn more at: NOT-OD-21-097. Deadline: Rolling.

4/2 – NIMH is issuing this Notice of Special Interest (NOSI) to highlight interest in research to understand the mental health impact of the Coronavirus Disease 2019 (COVID-19) pandemic on school-aged children, specifically ages 3 – 12. Learn more at: NOT-MH-21-225. Deadline: September 8, 2022.

4/2 – This Notice extends the special exception for preliminary data as post-submission material (see NOT-OD-20-123NOT-OD-20-163; and NOT-OD-20-179) to applications submitted for the January 2022 Council round due to COVID-19. Learn more at: NOT-OD-21-095. Deadline: Rolling.

4/2 – This notice corrects NOT-OD-21-071 “Notice of Special Interest (NOSI): Administrative Supplements and Urgent Competitive Revisions for NIH Grants to Add or Expand Research Focuses on Maternal Health, Structural Racism and Discrimination, and COVID-19” in the the “Key Dates” section and “Application and Submission Information” section. Learn more at: NOT-OD-21-090. Deadline: April 15, 2021.

4/2 – On March 16, 2021, NHLBI published NOT-HL-21-005 which provided additional guidance for currently-funded NHLBI K01, K08, K23, and K25 recipients impacted by COVID-19 seeking funded extensions. This updated Notice is being released to instruct applicants to submit electronically via PA-20-272 instead of a direct request to the applicable Grants Management Specialist and Program Official listed in the Notice of Award. New language is highlighted below in bold/italics. Learn more at: NOT-HL-21-009. Deadline: Rolling.

3/29 – The purpose of this notice is to clarify the Research Priorities, by including rural populations, and to emphasize the contextual research relevance to U.S., for projects relying on data or cohorts outside of the U.S. in RFA-AA-21-002 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R01 Clinical Trial Not Allowed).” Learn more at NOT-AA-21-009. Deadline: April 14, 2021.

3/29 – The purpose of this notice is to clarify the Research Priorities, by including rural populations, and to emphasize the contextual research relevance to U.S., for projects relying on data or cohorts outside of the U.S., in RFA-AA-21-003 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R03 Clinical Trial Not Allowed).” Learn more at NOT-AA-21-010. Deadline: April 14, 2021.

3/29 – The purpose of this notice is clarify the Research Priorities, by including rural populations, and emphasize the contextual research relevance to U.S., for projects relying on data or cohorts outside of the U.S. in RFA-AA-21-004 “SARS-CoV-2, COVID-19 and Consequences of Alcohol Use (R21 Clinical Trial Not Allowed).” Learn more at NOT-AA-21-011. Deadline: April 14, 2021.

3/29 – The focus of this NOSI is to inform the research community that the FIC is supporting administrative supplements (within the scope of parent award) to cover unanticipated costs caused by the COVID-19 pandemic or related mitigation efforts that could not be covered by re-budgeting existing funds. Learn more at NOT-TW-21-003. Deadline: May 15, 2021.

3/29 – The Fogarty International Center (FIC) requests applications for administrative supplements to existing FIC awards to support COVID-19-related research or mentored research projects on scientific questions unique to low- and middle-income countries. Applicants should only propose COVID-19-related research specific aims that can be accomplished during one year of administrative supplement support. Learn more at NOT-TW-21-004. Deadline: May 15, 2021.

3/19 – NINDS is interested in applications for supplements to human subjects awards administered by the NINDS to conduct research on the effects of COVID-19 on the development of, or disease progression in, Alzheimer’s Disease-Related Dementias (ADRDs). ADRDs include Frontotemporal Degeneration (FTD), Lewy Body Dementia (LBD), Vascular contributions to Cognitive Impairment and Dementia (VCID), and Mixed Etiology Dementias (MED). Learn more at NOT-NS-21-037. Deadline: May 6, 2021

3/19 – NHLBI investigators have been significantly affected by the COVID-19 pandemic, and several areas of need have been identified for early career scientists, in particular K01, K08, K23, and K25 recipients. To help support NHLBI career development award recipients, NHLBI is providing an opportunity for select K award recipients to apply for a funded extension to support their career development and successful transition to research independence. Learn more at NOT-HL-21-005. Deadlines: April 15, 2021, May 17, 2021, June 25, 2021.

03/10 – The National Institute of General Medical Sciences (NIGMS) announces the availability of administrative supplements for the Science Education Partnership Award (SEPA) (R25) grantees to develop educational resources to address SARS-CoV-2 vaccine hesitancy. Learn more at NOT-GM-21-032. Deadline: April 30, 2021.

03/03 – The National Institute on Aging (NIA) announces its interest in basic and clinical mechanistic research on neurological and neurocognitive sequelae originating from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection and Coronavirus Disease 2019 (COVID-19) in aging and age-related neurodegeneration. Learn more at NOT-AG-21-016. Deadline: May 8, 2023.

03/03 – NIGMS is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for modeling research on SARS-CoV-2 and Coronavirus Disease 2019 (COVID-19). Learn more at NOT-GM-21-019. Deadline: December 16, 2021.

03/03 – The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts by performing high-priority clinical studies and trials to test therapeutics for the Coronavirus Disease 2019 (COVID-19). Learn more at NOT-TR-21-022. Deadline: August 17, 2024.

03/01 – The National Institute of General Medical Sciences (NIGMS) announces the availability of urgent competitive revisions to support vaccine hesitancy research relevant to SARS-CoV-2. This NOSI is intended to provide funds for the Institutional Development Award (IDeA) (P20, P30, and U54) and Native American Research Centers for Health (NARCH) (S06) grantees to expand the scope of their active grants. Learn more at NOT-GM-21-021. Deadline: April 30, 2021.

02/10 – The National Institute on Drug Abuse (NIDA) is issuing this Notice of Special Interest (NOSI) inviting research applications to explore and develop telehealth methods and strategies for diagnosis, prevention, treatment, and population analysis in individuals living with HIV and Substance Use Disorder (SUD). Learn more at NOT-DA-21-019. Deadline: September 08, 2024.

02/04 – National Institute on Drug Abuse (NIDA) is interested in receiving research applications focusing on individuals with HIV who smoke or vape marijuana, tobacco, cocaine and/or methamphetamine to determine the long-term effects of their use among individuals with HIV and COVID-19. Learn more at NOT-DA-21-017. Deadline: September 08, 2024.

02/03 – Long-term neurocognitive aspects of COVID-19 are likely but still not fully understood. Thus, it is of major public health relevance to study the long-term neurocognitive consequences of the COVID-19, HIV and SUD’s syndemic, given the combined viral neurotropism of SARS-CoV-2, HIV-1, and the deleterious effects of SUDs in the brain. Learn more at NOT-DA-21-018. Deadline: September 08, 2024.

02/03 – The National Center for Advancing Translational Sciences (NCATS) is issuing this notice to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. Learn more at NOT-TR-21-017. Deadline: August 17, 2024

02/02 – Within existing constraints of available funding, NIH plans to support early career scientists whose career trajectories have been significantly affected by the pandemic. Therefore, NIH is providing an opportunity for recipients of NIH Fellowship (“F”) and NIH Career Development (“K”) awards who have been impacted by COVID-19 to request extensions. Learn more at NOT-OD-21-052.

01/27 – The National Institute on Alcohol Abuse and Alcoholism intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for addressing urgent, time-sensitive research questions on the relationships between alcohol consumption/misuse and COVID-19 related outcomes and consequences. This FOA will utilize the R21 activity code and clinical trials will not be allowed. Learn more at NOT-AA-21-003. Deadline: April 15, 2021.

01/27 – The National Institute on Alcohol Abuse and Alcoholism intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for addressing urgent, time-sensitive research questions on the relationships between alcohol consumption/misuse and COVID-19 related outcomes and consequences. This FOA will utilize the R03 activity code, and clinical trials will not be allowed. Learn more at NOT-AA-21-002. Deadline: April 15, 2021.

01/27 – The National Institute on Alcohol Abuse and Alcoholism intends to promote a new initiative by publishing a Funding Opportunity Announcement (FOA) to solicit applications for addressing urgent, time-sensitive research questions on the relationships between alcohol consumption/misuse and COVID-19 related outcomes and consequences. This FOA will utilize the R01 activity code and clinical trials will not be allowed. Learn more at NOT-AA-21-001. Deadline: April 15, 2021.

01/26 – The National Institute of Dental and Craniofacial Research (NIDCR) is issuing this Notice of Special Interest (NOSI) to encourage research studies focused on the physiological involvement of oral cavity and oral manifestations related to SARS-CoV-2 and/or Coronavirus Disease 2019 (COVID-19). Learn more at NOT-DE-21-001. Deadline: June 5, 2021.

01/26 – The purpose of this notice is to communicate NIDA’s interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. This Notice is a reissuance of NOT-DA-20-084. Learn more at NOT-DA-21-011. Deadline: June 5, 2021.

01/05 – The purpose of this Notice is to announce to potential applicants to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) an interest in research on the impact of COVID-19 as related to diseases and conditions within the NIAMS mission. Learn more at NOT-AR-21-012. Deadline: November 19, 2021.

12/23 – The purpose of this Notice is to outline priorities for providing supplemental funding to investigators and institutions with active National Institute of Mental Health (NIMH) awards that have been significantly impacted by the COVID-19 pandemic. Learn more at NOT-MH-21-120. Deadline: June 02, 2023

12/18 – The National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for projects that address the COVID-19 Public Health Emergency. The Clinical and Translational Science Award (CTSA) Program is uniquely qualified to contribute to these efforts. Learn more at NOT-TR-21-011. Deadline: June 02, 2021.

12/18 – This Notice of Special Interest (NOSI) highlights the need for research strategies and interventions to address vaccine hesitancy, uptake, and implementation among populations who experience health disparities in the US.* Research is needed to understand and address misinformation, distrust, and hesitancy regarding vaccines (e.g., SARS-CoV-2, pneumococcal, influenza, hepatitis B, human papilloma virus (HPV), and herpes zoster) among adults in the United States and territories, especially in populations at increased risk for morbidity and mortality due to long-standing systemic health and social inequities and chronic medical conditions. The purpose of this NOSI is to solicit community-engaged research to: 1) evaluate intervention strategies (e.g., expand reach, access) to facilitate vaccination uptake in clinical and community contexts; and 2) address the barriers to increasing reach, access, and uptake of vaccinations among health disparity populations at high risk and likely to experience vaccine hesitancy. Learn more at NOT-MD-21-008. Deadline: January 8, 2022.

11/13 – NIAID is issuing this Notice of Special Interest (NOSI) to highlight the critical need to develop prophylactic vaccines able to provide broad and durable protection against coronaviruses (CoVs), especially SARS-CoV-2 and others with pandemic potential. Learn more at NOT-AI-21-002. Deadline: June 12, 2021.

10/27 – The purpose of this notice is to communicate NIDA’s (National Institute on Drug Abuse) interest in supporting research on the effects of smoking or vaping tobacco or marijuana on the risk of acquiring COVID-19 and the clinical course of the infection. Learn more at NOT-DA-20-084. Deadline: September 08, 2024.

9/29 – The purpose of this NOSI is to encourage applications in three areas related to the intersection of COVID-19, the associated mitigation actions, and rehabilitation. Research applications addressing these topics are considered responsive; not all topics are expected within the same application. Applications will be directed to the National Center for Medical Rehabilitation Research (NCMRR) at NICHD. Learn more at NOT-HD-20-031. Deadline: May 08, 2023.

8/17 – The purpose of this funding opportunity announcement (FOA) is to support research on interventions to improve health in Native American (NA) populations. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Learn more at PAR-20-238. Deadline: May 17, 2021, May 17, 2022, May 17, 2023.

8/13 – The purpose of this Notice of Special Interest is to support investigative and collaborative research focused on developing and evaluating simulation modeling and systems science to understand and address minority health and health disparities. Learn more at NOT-MD-20-025. Deadline: May 08, 2023.

8/13 – This Notice of Special Interest encourages cooperative agreement applications for implementation of investigator-initiated high-risk clinical trials, as defined by NIAID in PAR-18-633 and NOT-AI-16-084, that will augment ongoing and planned clinical trials of therapeutic and vaccine candidates directed against SARS-CoV-2 to evaluate: SARS-CoV-2 candidate vaccines non-vaccine biomedical prevention of SARS-CoV-2 infection and/or COVID-19 therapeutic approaches to treat COVID-19. Learn more at NOT-AI-20-065. Deadline: September 01, 2021.

8/05 – The purpose of this urgent funding opportunity announcement is to invite applications to repurpose existing therapeutic agents to treat Coronavirus Disease 2019 (COVID-19) sequelae and associated complications that result from Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections. The therapeutic agent must have already completed at least a Phase I clinical trial for a different indication, and not require additional regulatory studies for the new indication prior to starting a clinical trial. Learn more at RFA-TR-20-003. Deadline: Applications will be accepted on a rolling basis, beginning on August 6, 2020. All applications are due by 5:00 PM local time of applicant organization.

7/17 – The purpose of this public health emergency funding opportunity is to provide Personal Protective Equipment (PPE) to directly support the needs of the NIAID’s vaccine and treatment clinical trials and clinical studies for COVID-19. This program will ensure that adequate protective equipment is available to directly assist in safely carrying out the clinical activities and direct interactions with the patients participating in the trial. Learn more at PAR-20-256. Deadline: Rolling basis, until July 08, 2021.

7/06 – NIAID is issuing a notice to highlight very specific and limited needs for Competitive Revision applications to active NIAID grants in order to further build the infrastructure that NIAID needs to support SARS-CoV-2 and COVID-19 research response. This NOSI replaces NOT-AI-20-034 which was rescinded with this issuance of this Notice. Learn more at NOT-AI-20-059. Deadline: July 02, 2020 through July 02, 2021.

6/25 – Leidos Biomedical Research, Inc. (Leidos Biomed) has issued an RFP for Capacity Building Centers to support the Serological Sciences Network (SeroNet), developed to mobilize collaborative efforts to develop serological assays of high specificity and high sensitivity for deployment to test for SARS-CoV-2 induced immune responses and to rapidly expand national serological testing capacity. Learn more at NOT-CA-20-077.

6/25 – NIH has issued a notice to highlight the urgent need for research on COVID-19 in individuals with Down syndrome in conjunction with the INCLUDE Project. The overarching goal of this NOSI is to improve understanding and treatment of COVID-19 infection in individuals with Down syndrome and reduce COVID-19 associated morbidity and mortality for this population, which may be disproportionately affected by, have higher infection rates of, and/or be at elevated risk for adverse outcomes from contracting the virus. Learn more at NOT-OD-20-129.

6/15 – The National Center for Advancing Translational Sciences (NCATS) has issued a notice for Administrative Supplements (through PA-18-591) from current Clinical and Translational Science Award (CTSA) UL1 and U24 award recipients. Learn more at NOT-TR-20-029.

4/30 – NINDS has issued a notice to highlight the urgent need for research on COVID-19 and on biological effects on the nervous system of its causative agent, SARS-CoV-2. Research of interest must fall within NINDS’s scientific mission, which is to support basic, translational, and clinical neuroscience research to expand fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease. Learn more at NOT-NS-20-051. Deadline: April 15, 2021.

4/30 – NIAID has issued a FOA to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly for COVID-19. R21 Clinical Trial Not Allowed. Learn more at PAR-20-177. Deadline: Rolling.

4/30 – NIAID has issued a FOA to improve understanding of fundamental virology, immunology, and the development of animal models, reagents, and medical countermeasures and to share findings quickly and broadly for COVID-19. R01 Clinical Trial Not Allowed. Learn more at PAR-20-178. Deadline: Rolling.

4/29 – The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Learn more at Rapid Acceleration of Diagnostics (RADx). Deadline: Rolling.

4/16 -National Institute on Alcohol Abuse and Alcoholism (NIAAA) has issued a notice to understand the potentially complex relationships between alcohol consumption and COVID-19 related-outcomes to enhance the nation’s response to the current pandemic. Learn more at NOT-AA-20-011. Deadline: April 16, 2021.

4/09 – National Institute of Environmental Health Sciences (NIEHS) is issuing this Notice of Special Interest (NOSI) to address the urgent need for mission-relevant research to understand the impact of environmental exposures on Coronavirus Disease 2019 (COVID-19) and its causative agent, the severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2). Learn more at NOT-ES-20-015. Deadline: May 4, 2021.

4/09 – National Institute on Minority Health and Health Disparities (NIMHD) has issued a notice to highlight the urgent need for research on the impact of the novel Coronavirus (SARS-CoV-2) pandemic causing COVID-19 disease outbreaks and the resulting disruptions on individual and social wellbeing, health services use, and health outcomes for NIH-designated health disparity populations. Learn more at NOT-MD-20-019. Deadline: May 1, 2021.

4/09 – National Institute of Mental Health (NIMH) has issued a notice to highlight interest in research to strengthen the mental health response to Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and to future public health emergencies, including pandemics. Learn more at NOT-MH-20-047. Deadline: April 16, 2021.

4/09 – National Center for Advancing Translational Sciences (NCATS) has posted NOT-TR-20-016 and NOT-TR-20-017 to highlight the urgent need for research in the use of microphysiological systems or tissue chips in collecting and examining data on the risks and outcomes for COVID-19 infection, and advance the translation of research findings into diagnostics, therapeutics, and vaccines. Deadline: January 26, 2022.

4/02 – In order to rapidly improve understanding and available control measures for 2019-nCoV, National Institute on Aging (NIA) is encouraging the submission of applications for either Administrative Supplements (PA-18-591) or Competitive Revisions (PA-18-935) to active grants to address research areas of interest. Learn more at NOT-AG-20-022. Deadline: May 1, 2021.

3/24 – National Center for Advancing Translational Sciences (NCATS) has issued this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel Coronavirus (COVID-19). NCATS is particularly interested in projects focusing on the use of informatics solutions to diagnose cases and the use of CTSA-supported core resources (e.g., advanced scientific instruments, highly-specialized facilities, and regulatory expertise) to facilitate research on COVID-19 and advance the translation of research findings into diagnostics, therapeutics, and vaccines. Learn more at NOT-TR-20-011. Deadline: July 10, 2021.

 Back to Top

National Science Foundation (NSF)

07/17 – NSF has issued a notice to highlight the interest of existing programs in the Directorate for Biological Sciences (BIO) and the Directorate for Engineering (ENG) in interdisciplinary research for the development of novel biological platforms that are capable of sensing and responding to emerging infectious agents. The mechanism of sensing should be adaptable and or evolvable such that the sentinel cells, or other appropriate biotechnology solutions, are robust to a range of emergent threats, and/or can easily be reprogrammed and deployed once a new threat is identified. Learn more at NSF 20-105

04/17 – NSF has issued a letter to researchers inviting proposals for rapid response research grants related to the virus. The letter welcomes studies to help understand COVID-19, inform and educate the public about virus transmission and prevention, and develop effective strategies for addressing this challenge at the local, state and national levels. Learn more at NSF 20-052. Deadline: Rolling.

 Back to Top

Office of Science and Technology Policy

3/16 – In response to the COVID-19 pandemic, the Allen Institute for AI has partnered with leading research groups to prepare and distribute the COVID-19 Open Research Dataset (CORD-19), a free resource of over 29,000 scholarly articles, including over 13,000 with full text, about COVID-19 and the coronavirus family of viruses for use by the global research community. The White House has issued a call to action to the Nation’s artificial intelligence experts to develop new text and data mining techniques that can help the science community answer high-priority scientific questions related to COVID-19. Learn more at Call to Action to the Tech Community on New Machine Readable COVID-19 Dataset. Deadline: Rolling.

 Back to Top

White House

3/23 – Researchers are invited to submit COVID-19 related research proposals to the COVID-19 High Performance Computing Consortium via the online portal which will then be reviewed and matched with computing resources from one of the partner institutions. An expert panel of top scientists and computing researchers will work with proposers to quickly assess the public health benefit of the work and coordinate the allocation of the group’s powerful computing assets. Learn more at White House Announces New Partnership to Unleash U.S. Supercomputing Resources to Fight COVID-19. Deadline: Rolling.

 Back to Top

 

COVID-19 Non-Federal Funding

GrantForward has provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Grant COVID. Candid has also provided free access to a list of funding opportunities in the area of COVID-19 that will be updated on a daily basis at Funding Opportunities.

American Lung Association

04/20 – The American Lung Association is launching a $25M initiative to end COVID-19 and defend against future respiratory virus pandemics. Learn more at COVID-19 Action Initiative. Deadline: Rolling.

 Back to Top

Andrew W. Mellon Foundation

09/17 – As part its emergency grantmaking in the face of the global COVID-19 crisis, The Andrew W. Mellon Foundation announced today the launch of a new Art Museum Futures Fund — an emergency grant program starting with nearly $24 million to be distributed to 12 midsized art museums across the nation. Learn more at Art Museum Futures Fund.

 Back to Top

Boehringer Ingelheim

08/07 –  Established Products: Evaluate potential clinical and non-clinical investigations involving COVID-19 related matters including safety, clinical outcomes, antiviral effects, or antithrombotic benefits. Learn more at Investigator Initiated Studies (IIS). Deadline: Rolling.

 Back to Top

California Breast Cancer Research Program (CBCRP)

04/06 – In light of the emergence and spread of COVID-19 in California and beyond, the statewide funding programs of the University of California Office of the President (UCOP) Research Grants Program Office (California Breast Cancer Research Program (CBCRP), Tobacco-Related Disease Research Program (TRDRP), California HIV/AIDS Research Program (CHRP)) and the Type 1 Diabetes Research Fund are together making available up to $2M to immediately support urgent research to mitigate the pandemic. Learn more at emergency COVID-19 Research Seed Funding. Deadline: Rolling.

 Back to Top

Coalition for Epidemic Preparedness Innovations (CEPI)

02/14 – CEPI issues calls for proposals and requests for information inviting applicants to submit proposals for projects to develop vaccine candidates and support clinical trials involving vaccine candidates. Learn more at Call for Proposals. Deadline: Rolling.

 Back to Top

COVID-19 Early Treatment Fund

4/9 – CETF is the only organization in the world that exclusively funds outpatient clinical trials for COVID-19 treatments. Learn more at: Call for Proposals. Deadline: Rolling.

 Back to Top

DRIVe

4/9 -BARDA DRIVe, in partnership with the National Institute for Occupational Safety and Health (NIOSH), is proud to present the “Mask Innovation Challenge: Building Tomorrow’s Mask”. This challenge aims to support the development of innovative masks that can protect Americans from respiratory pathogens such as SARS-CoV-2. Learn more at Call for Proposals. Deadline: April 21, 2021.

 Back to Top

Google

10/12 – Google has partnered with the Harvard Global Health Institute to fund companies, government agencies, non-profit organizations and academic institutions working on COVID-19 research. Researchers in approved countries are eligible to apply for COVID-19 related research credits. Learn more at Research Grants. Deadline: Rolling.

 Back to Top

Patient-Centered Outcomes Research Institute

3/19 – This Eugene Washington PCORI Engagement Awards Special Cycle Funding Announcement—Building Capacity for PCOR/CER for Topics Related to COVID-19 is a research support – not research—special funding opportunity for projects up to 18 months in duration and up to $200,000 in total costs. This special funding opportunity will support projects that enable organizations and communities to build their capacity and skills to participate across all phases of the PCOR/CER process on topics that address health outcomes related to COVID-19. Learn more at Engagement Award Special Cycle: Building Capacity for PCOR/CER for Topics Related to COVID-19. Deadline: May 24, 2021.

 Back to Top

Paul Scherrer Institut

02/22 – PSI has opened a “PRIORITY COVID-19 Call” for short proposals and quick peer review to enable rapid access to beamtime. Research proposals shall have the potential to effectively contribute to the understanding of the virus and/or to improve the clinical or public health response and patient care. This “PRIORITY COVID-19 Call” is explicitly for projects requiring a rapid access to beamtime within the next months. Learn more at Priority access call for work on combating COVID-19. Deadline: Rolling

 Back to Top

Russell Sage Foundation

02/18 – RSF will accept LOIs under these core programs and special initiatives: Behavioral Economics; Decision Making & Human Behavior in Context; Future of Work; Social, Political and Economic Inequality. In addition, RSF will also accept LOIs relevant to any of its core programs that address at least one of the following issues: (1) Research on the Covid-19 pandemic and the resulting recession in the U.S. (2) Research focused on systemic racial inequality and/or the recent mass protests in the U.S. Learn more at Funding Opportunities . Deadline: May 4, 2021.

 Back to Top

Stop the Spread

01/12 – We are keenly focused on working with companies and organizations —large and small—to spur development of PPE for both medical and non-medical use, novel testing solutions, widely-accessible therapeutics and digital health solutions to address the needs of underserved communities and vulnerable populations. As the crisis evolves, we will continue to be responsive by tackling other urgent priorities. We also seek to connect with community and faith based organizations, community leaders, healthcare providers and philanthropists who would be interesting in partnering with us to #StoptheSpread in the hardest hit communities. Learn more at Stop the Spread. Deadline: ongoing.

 Back to Top

Trinity Challenge

01/15 – The Trinity Challenge seeks insights, new approaches and novel tools across the categories of (1) Identification, (2) Response and (3) Recovery. Learn more at The Trinity Challenge. Deadline: April 15, 2021.

 Back to Top

Wellcome

02/18 – Innovator Awards are open to researchers who are developing healthcare innovations that could have a major and measurable impact on human health. Learn more at Innovator Awards. Deadline: 24 May 2021, 17:00 BST.

 Back to Top

W.K. Kellogg Foundation

01/12 – Children are at the heart of everything at the Kellogg Foundation. Their goal is lasting, transformational change for children. As a grantmaker, they recognize that children live in families and families live in communities. Therefore, their three areas of focused work – Thriving Children, Working Families and Equitable Communities – are dynamic and always interconnected. Learn more at Grantseekers. Deadline: Ongoing except between Jan. 23 through Mar. 14.

 Back to Top